Biphenyl Compounds
Research News and Information

Monday, November 23, 2009

Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam.

Nov 2009 Mechanism-based inhibitors of class A beta-lactamases, such as sulbactam, undergo a complex series of chemical reactions in the enzyme active site. Formation of a trans-enamine acyl-enzyme via a hydrolysis-prone imine is responsible for transient ... Read more...

An evaluation of extracts of five traditional medicinal plants from Iran on the inhibition of mushroom tyrosinase activity and scavenging of free radicals.

29 Sep 2009 This study aimed to evaluate the free radical scavenging and inhibition properties of five medicinal plants, including Quercus infectoria Olive., Terminalia chebula Retz., Lavendula stoechas L., Mentha longifolia L., Rheum palmatum L., toward the ... Read more...

Inhibitory effects of honokiol on LPS and PMA-induced cellular responses of macrophages and monocytes.

28 Sep 2009 The regulatory effects of honokiol on the cellular responses of macrophages and monocytes were evaluated. Specifically, we investigated the effects of honokiol with respect to lipopolysaccharide (LPS)-induced cytotoxicity, LPS- or ... Read more...

Latest indexed articles for 'Biphenyl Compounds'

These are the very latest articles for this heading:

• Role of E166 in the imine to enamine tautomerization of the clinical beta-lactamase inhibitor sulbactam. Nov 2009
• An evaluation of extracts of five traditional medicinal plants from Iran on the inhibition of mushroom tyrosinase activity and scavenging of free radicals. 29 Sep 2009
• Inhibitory effects of honokiol on LPS and PMA-induced cellular responses of macrophages and monocytes. 28 Sep 2009
• Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats. 24 Sep 2009
• Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity. 22 Sep 2009
• Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. 15 Sep 2009
• Effect of initiator on photopolymerization of acidic, aqueous dental model adhesives. 13 Sep 2009
• Radical scavenging activity of lipophilized products from transesterification of flaxseed oil with cinnamic acid or ferulic acid. 30 Aug 2009
• Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. 30 Aug 2009
• Self-assembly of double-tail anionic surfactant having cyanobiphenyl terminal groups in water. 30 Aug 2009
• Contribution of a significant first-pass effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate in the liver to its poor bioavailability in rats. 30 Aug 2009
• Antioxidant and antibacterial activities of eugenol and carvacrol-grafted chitosan nanoparticles. 30 Aug 2009
• Fluorogenic derivatization of aryl halides based on the formation of biphenyl by Suzuki coupling reaction with phenylboronic acid. 19 Aug 2009
• Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation. 15 Aug 2009
• Dealcoholized wines by spinning cone column distillation: phenolic compounds and antioxidant activity measured by the 1,1-diphenyl-2-picrylhydrazyl method. 10 Aug 2009
• Lubiprostone stimulates duodenal bicarbonate secretion in rats. 4 Aug 2009
• The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance. 30 Jul 2009
• Matrix elimination ion chromatography method for trace level azide determination in irbesartan drug. 30 Jul 2009
• The impacts of aggregation and surface chemistry of carbon nanotubes on the adsorption of synthetic organic compounds. 30 Jul 2009
• Candesartan: widening indications for this angiotensin II receptor blocker? 30 Jul 2009

See a longer list of these articles.

Technical information about 'Biphenyl Compounds'

Registry Number: 0

Descriptor UI: D001713

Alternative terms: Biphenyl Compounds; Compounds, Biphenyl;

Allowable Qualifiers: metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification;

Tree Number: D02.455.426.559.389.185;

Technical Notes: DF: BIPHENYL CPDS